Wing Kin Liu

@Alex__Georgiou @GSTTnhs @spyrosgennatas @DrDanielJHughes @GuysCancerC Amazing work everyone!

Very proud of the clinical research presented by @GSTTnhs Lung Cancer team at #BTOG26. Congratulations to Dr Holdich who showcased our work in lung cancer in never smokers and won first prize for poster presentation. 👏👏@spyrosgennatas @DrDanielJHughes @GuysCancerC

I am delighted to be fundraising for Guy's Cancer Charity by running the London Marathon. Check out my @JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/page/wing-liu-…

It was a pleasure to present my research at ESMO this year. I'm honored to receive a merit award for my abstract and many thanks to @CharlesSwanton and Mariam Jamal-Hanjani for supervising and supporting this research #ESMO2025

🎥@wingkinliu of @GSTTnhs shares South-East England’s experience with reflex molecular biomarker testing in CRC: 🔎 107 pts studied ⏱️ Only 1 had results by 1st MDT ⚠️ Just 20% by 1st oncology appt → risk of suboptimal initial therapy ➡️ow.ly/ZE1e50WHagj @myESMO #CRCSM #GI25 #Oncology This podcast is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Takeda. Supporters have no influence over the production of content.

Great to speak with @VJOncology at #ESMOGI25 about the role of reflex testing in colorectal cancer across South East England. 🎥 Watch the full interview: youtu.be/x5pqdTYsAn0?si… via @YouTube #ColorectalCancer #Oncology #PrecisionMedicine

Had a great time presenting my poster on the ctDNA transformation pilot for patients with advanced NSCLC in South East England at the BTOG conference. Hope to be back next year! #btog #nhsengland #ctdna

Gael Monfils & Giovanni Mpetshi Perricard cooling down together after their match at Australian Open 3 hours & 45 minute match Brutal 5 setter But when it’s over, there are no winners or losers Just 2 friends riding their bikes, having a chat 🚲 🚲

heatmap in ggplot2 yunuuuu.github.io/ggalign/articl… I always use complexheatmap, but this seems to be a good alternative if you want to stay within the ggplot. #rstats

Unexpected and slightly overwhelming news from @uclmedsci. I am extremely grateful to @CRUKresearch for their constant support and most importantly the incredible scientists @uclcancer past and present who made this happen. A privilege to stand on the shoulders of giants.

Writing a scientific article: A step-by-step guide for beginners (1/7)

Hi everyone, I will be running the Royal Parks half marathon to raise money for Cure Cancer. We are aiming to buy a new flow cytometer for the UCL Cancer Institute. Please donate if you can, every little helps! @CureCancerUCL @uclcancer @RoyalParksHalf app.goodhub.com/cure-cancer-at…

Life lessons from @rogerfederer (must watch) 1 Effortless is a myth 2 Belief in yourself has to be earned 3 Grit > Gift 4 Discipline is talent 5 Trust and loving the process is talent 6 You can do your best and still lose 7 Life is bigger than the court

@NickyMcGranahan @BlavatnikAwards @uclcancer @CRUKCOLcentre @CRUKLungCentre Excellent and very wise words about research at the end of the video!

The @BlavatnikAwards made a little video about our lab and the work we do: youtube.com/watch?v=-o43Bf… @uclcancer @CRUKCOLcentre @CRUKLungCentre

Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’

📣Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) @Annals_Oncology @myESMO ➡️ctDNA ➡️For now, plasma should be used. But in future, disease-specific sample may be used (urine, bile) ➡️In metastatic setting, used to evaluate the response. In earlier disease settings, it may be game changer to follow MRD and may lead treatment choice/intensity. ➡️Should be measured at multiple time points at regular intervals, incorporating with imaging ➡️Should be measured 4 weeks after surgery ➡️Solely or with imaging? Or when imaging fails to give definitive result? Head to head comparison between imaging and ctDNA would be ideal ➡️Technology: Detection of ctDNA mutations, methylation, tumor tissue-informed approach: standardizing is challenging ➡️Negative in baseline? Brain-only disease? Changes according to the type of therapy? ➡️In fact, clinical trials have started to incorporate ctDNA ➡️Regulatory issues ✅Authors suggested a useful trial design👇 👉annalsofoncology.org/article/S0923-… @mgoudaMD @curijoey @VivekSubbiah @MDAndersonNews @ESMO_Open @EMA_News @FDAOncology @DenizCanGuven1 @DrHongchengZhu @pawel_sobczuk @ekocakavuk #cancer #Oncology #treatment #MedX

We're absolutely over the moon that @tompowles1 is included in @Nature 's global list of ‘the 10 people who shaped science in 2023’. His work on new treatment for #bladdercancer was recognised as a world-class contribution to science. Congratulations! qmul.ac.uk/media/news/202…

Really enjoyed #ESMO2023. Thrilled to present recent work from TRACERx & PEACE showing genetic immune evasion alterations are heterogeneous across NSCLC mets. Thanks to @CharlesSwanton, @MariamJHanjani and #CRUK. Congrats to @crispinhiley @wingkinliu @dr_yinwu @jrm_black

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

Wonderful summary of TRACERx latest data by Prof Mitsudomi reviewing ⁦@crispinhiley⁩ ⁦@SonyaHessey⁩ and Wing Liu work - Clonal TMB , metastasis growth rates and Immune evasion mechanisms - thanks ⁦@TheCrick⁩ ⁦@uclcancer⁩ ⁦@CRUK_MI⁩ @CRUKresearch⁩